In This Section
AIPLA CLE Webinar: Protecting and Enforcing Chemical and Pharmaceutical Inventions in India
November 15, 2022 12:30 PM to 2:00 PM
The importance of protecting chemical and pharmaceutical inventions in India, cannot be overstated. The Indian pharmaceutical industry is the world’s third largest by volume and fourteenth largest in terms of value. India is also the largest provider of generic drugs globally. In this webinar, the speaker Mr. Sharad Vadehra, who is one of the leading Patent Attorneys in India having experience of over 32 years in drafting, prosecuting and litigating chemical and pharmaceutical patent applications; is going to elaborate on how to obtain and enforce chemical and pharmaceutical Patents in India. Mr. Sharad Vadehra, while focusing on unique aspects under Indian law, will cover varied topics, inter alia, protectable inventions in India, patent eligibility requirements, handling office actions, pitfalls to avoid and recent case laws.
Presented by: Sharad Vadehra, Kan and Krishme
This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. CLE is included for our All Access Pass holders and Corporate Subscribers.
Pricing below only applies to those requesting CLE
Special rate for AIPLA SOLO PRACTICE/SMALL FIRM MEMBERS: $65
Special rate for AIPLA STUDENT MEMBERS: $10
In response to Covid-19, AIPLA has put in-place a new process for Multiple Attendee Site registrations that allows each site registrant to participate in the webinar independently.
Registration includes:
- For multiple-attendee sites, each registered participant will receive individual logins due to Covid-19 social distancing requirements.
- CLE certification/processing for applicable states. Reference CLE Information below for complete details.
- Webinar materials, including complete CLE processing information, accessible 24-48 hours before webinar date.
Cancellation Policy:
To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product.
System requirements:
Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices. Check system compatibility here.
Accessibility for hearing impaired:
AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.
CLE INFORMATION
CLE is approved with the following states:
- Alaska
- Missouri
- New Jersey (Under New Jersey's Reciprocity Rule)
- New York (Under New York's Approved Jurisdiction Policy)
- Pennsylvania
- Texas
- Vermont
AIPLA has applied for CLE accreditation in the following states:
- Florida
- Illinois
- Minnesota
- Ohio
- Tennessee
- Virginia
- Washington
CLE Restrictions:
ATTENTION attorneys in Louisiana, Ohio, Pennsylvania, and Utah
These states mandate attorneys can only view a webinar independently at their own computer to receive CLE credit. Multiple attendees prohibited.
ATTENTION attorneys in Alabama and Rhode Island
AIPLA does not submit courses for approval in Alabama or Rhode Island. Attendees needing credit in these states may select the free, no CLE option to watch the webinar and use course materials and their certificate of attendance to request course approval directly from the State Bars.
ATTENTION attorneys in Arizona
Arizona does not certify courses or providers. Arizona lawyers are required to independently review AZ's regulations and make their own determination that it qualifies for credit towards their MCLE requirements. MCLE Regulation 104(A) identifies the standards to apply. AIPLA will email an attendance affidavit to registrants requesting AZ CLE credit after the webinar.
ATTENTION attorneys in New Hampshire
New Hampshire attendees must self-determine whether a program is eligible for credit, and self-report their attendance according to NH Supreme Court Rule 53. The New Hampshire Minimum Continuing Legal Education (NHMCLE) Board does not approve or accredit CLE activities for the NH Minimum CLE requirement. AIPLA will email an attendance affidavit to registrants requesting NH CLE credit after the webinar.
Disclaimer: AIPLA is a nonprofit national bar association. The sole purpose of this CLE program is to provide educational and informational content. AIPLA does not provide legal services or advice. The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors. These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.
News
-
AIPLA Files Amicus Brief with the Court of Appeals for the Federal Circuit in Google LLC v. Sonos, Inc.
March 21, 2024
Arlington, VA. February 29, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in Google LLC v. Sonos, Inc., a case on appeal from the U.S. District Court for the Northern District of California. The district court held that the post-GATT patents-in-suit are unenforceable under the doctrine of prosecution laches and found unreasonable and inexcusable delay where 13 years had elapsed between the provisional patent application and presenting the claims at issue. -
AIPLA Comments to Copyright Office on Group Registration of Updates to a News Website
February 22, 2024
Arlington, VA. February 20, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of updates to a news website. -
AIPLA Comments to HHS on WHO Pandemic Treaty
February 8, 2024
Arlington, VA. January 31, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the RFC on Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the World Health Organization (WHO) Pandemic Agreement. -
AIPLA Comments to NIST on March-In Rights Guidance
February 7, 2024
Arlington, VA. February 5, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the National Institute of Standards and Technology (NIST) in response to the Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights. -
AIPLA Comments to Federal Trade Commission on Proposed Rulemaking Regarding Consumers “Right to Repair”
February 5, 2024
Arlington, VA. February 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the Federal Trade Commission (FTC) in response to the petition for rulemaking to protect consumers’ right to repair products they have purchased.